Leonteq Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.4M Hold
400,000
– – 0.47% 40
2026
Q2
$9.6M Hold
400,000
– – 0.33% 51
2026
Q1
$11.2M Sell
400,000
-200,000
-33% -$5.32M 0.42% 50
2025
Q4
$14.9M Buy
600,000
+200,000
+50% +$5.04M 0.46% 36
2025
Q3
$10.2M Buy
+400,000
New +$9.9M 0.31% 58
2024
Q3
– Sell
-100,000
Closed -$2.8M – 1256
2024
Q2
$2.8M Buy
+100,000
New +$2.75M 0.2% 94
2024
Q1
– Sell
-1,100
Closed -$31.7K – 1257
2023
Q4
$31.7K Buy
+1,100
New +$33.3K ﹤0.01% 862

Other funds holding PFE

Leonteq Securities's PFE Position: Q3 2026 in Review

Leonteq Securities increased its Pfizer (PFE) stake by 87% in Q3 2026, buying an estimated $1.57M and bringing the position to 126,855 shares worth $3.62M. The position accounts for 0.15% of the portfolio, ranked #110.

Leonteq Securities first reported a position in PFE in Q4 2020 and has held it in 24 quarters since. The position peaked at $26.2M in Q2 2025. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Leonteq Securities held 126,855 shares of Pfizer worth $3.62M as of Q3 2026.
  • Leonteq Securities bought 59,164 Pfizer shares in Q3 2026, an estimated $1.57M.
  • Pfizer made up 0.15% of Leonteq Securities's portfolio in Q3 2026, its #110 holding.
  • Leonteq Securities first reported a position in Pfizer in Q4 2020 and has held it in 24 quarters since.
  • Leonteq Securities's Pfizer position peaked at $26.2M in Q2 2025.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.